Ditsch N, Liebhardt S, Von Koch F, Lenhard M, Vogeser M, Spitzweg C, Gallwas J, Toth B - "Thyroid function in breast cancer patients" Anticancer Res. 30(5):1713-7 (2010)
https://ar.iiarjournals.org/content/30/5/1713
"Recent studies showed increased serum levels of thyroid-stimulating hormone (TSH), with subclinical or manifest hypothyroidism in 10.0-19.7% of breast cancer patients (3, 4)."
Kim EY, Chang Y, Lee KH, Yun JS, Park YL, Park CH, Ahn J, Shin H, Ryu S - "Serum concentration of thyroid hormones in abnormal and euthyroid ranges and breast cancer risk: A cohort study" Int J Cancer 145(12):3257-3266 (2019)
https://pubmed.ncbi.nlm.nih.gov/30882890/
Szychta P, Szychta W, Gesing A, Lewiński A, Karbownik-Lewińska M - "TSH receptor antibodies have predictive value for breast cancer - retrospective analysis" Thyroid Res 6(1):8 (2013)
https://pubmed.ncbi.nlm.nih.gov/23680448/
Fröhlich E, Wahl R - "Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases" Front Immunol 8:521 (2017)
https://pubmed.ncbi.nlm.nih.gov/28536577/
Govindaraj V, Yaduvanshi NS, Krishnamachar H, Rao AJ - "Expression of thyroid-stimulating hormone receptor, octamer-binding transcription factor 4, and intracisternal A particle-promoted polypeptide in human breast cancer tissues" Horm Mol Biol Clin Investig 9(3):173-8 (2012)
https://pubmed.ncbi.nlm.nih.gov/32056382/
Nisman B, Allweis TM, Carmon E, Kadouri L, Maly B, Maimon O, Meirovitz A, Peretz T - "Elevated Free Triiodothyronine Is Associated With Increased Proliferative Activity in Triple-negative Breast Cancer" Anticancer Res 41(2):949-954 (2021)
https://pubmed.ncbi.nlm.nih.gov/33517301/
Nisman B, Allweis TM, Carmon E, Kadouri L, Maly B, Maimon O, Meierovich A, Peretz T - "Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary Breast Cancer" Anticancer Res 40(11):6417-6428 (2020)
https://pubmed.ncbi.nlm.nih.gov/33109580/
Szychta P, Szychta W, Gesing A, Lewiński A, Karbownik-Lewińska M - "TSH receptor antibodies have predictive value for breast cancer - retrospective analysis" Thyroid Res 6(1):8 (2013)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662571/
Limanova Z, Barkmanova J, Friedmanova Z - "The frequent incidence of thyropathies in women with breast carcinoma" Vntir Lek 44: 76-82 (1998)
Klubo-Gwiezdzinska J - "Thyroid Hormones Enhance the Growth of Estrogen Receptor-Positive Breast Cancers" Clin Thyroidol 34(7):286-289 (2022) doi: 10.1089/ct.2022;34.286-289
https://pubmed.ncbi.nlm.nih.gov/36937987/
"The study reveals clinically significant associations between THRT and worse outcomes in patients with nonmetastatic SR+ breast cancer that are likely driven by interactions between the nuclear ERs and THRs, leading to upregulation of pro-oncogenic signaling."
More studies - Thyroid & Breast Cancer
-
- Site Admin
- Posts: 5777
- Joined: Tue Jan 18, 2005 10:25 pm